SNo |
IS Number |
Title |
Technical Committee |
1 |
IS/ISO 10993 : Part 3 : 2014 |
Biological evaluation of medical devices Part 3 Tests for Genotoxicity, Carcinogenicity and Reproductive toxicity (First Revision) |
MHD 19 |
2 |
IS/ISO 10993 : Part 4 : 2017 |
Biological evaluation of medical devices Part 4 Selection of tests for interactions with blood |
MHD 19 |
3 |
IS/ISO 10993 : Part 5 : 2009 |
Biological evaluation of medical devices Part 5 Tests for in vitro cytotoxicity |
MHD 19 |
4 |
IS/ISO 10993 : Part 6 : 2016 |
Biological evaluation of medical devices Part 6 Tests for local effects after implantation |
MHD 19 |
5 |
IS/ISO 10993 : Part 7 : 2018 |
Biological evaluation of medical devices Part 7 Ethylene oxide sterilization residuals |
MHD 19 |
6 |
IS/ISO 10993 : Part 9 : 2009 |
Biological evaluation of medical devices Part 9 Framework for identification and quantification of potential degradation products |
MHD 19 |
7 |
IS/ISO 10993 : Part 10 : 2010 |
Biological evaluation of medical devices Part 10 Tests for irritation and skin sensitization |
MHD 19 |
8 |
IS/ISO 10993 : Part 11 : 2017 |
Biological evaluation of medical devices Part 11 Tests for systemic toxicity |
MHD 19 |
9 |
IS/ISO 10993 : Part 15 : 2000 |
Biological evaluation of medical devices: Part 15 identification and quantification of degradation products from metals and alloys |
MHD 19 |
10 |
IS/ISO 10993 : Part 16 : 2017 |
Biological Evaluation of Medical Devices Part 16 Toxicokinetic Study Design for Degradation Products and Leachables |
MHD 19 |
11 |
IS/ISO 10993 : Part 17 : 2002 |
Biological Evaluation of Medical Devices Part 17 Establishment of Allowable Limits for Leachable Substances |
MHD 19 |